Albireo to showcase new data at aasld the liver meeting® 2022

– seven abstracts accepted, including one oral presentation highlighting long-term data demonstrating bylvay ® (odevixibat) durable efficacy in patients with all types of pfic
ALBO Ratings Summary
ALBO Quant Ranking